vialaudit

affiliate disclosure · We earn affiliate commission on some vendor links. Audits, scores, and rankings are independent — vendors do not pay for placement and do not see drafts. read more →

vendor audit · prime-research-peptides

Prime Research Peptidescomposite 74/100

last tested · · 2 days ago
composite score
74/100
weighted: 40% purity · 25% label · 20% shipping · 15% support
  • purity / coa65/100
  • shipping75/100
  • pricing90/100
  • support70/100

Aggressively-priced US-based vendor that carries the full GLP-1 mainstream — Retatrutide, Tirzepatide, and Semaglutide all in one catalog. Public-facing brand "Prime Research Peptides" appears to be a storefront for Truform Compounds (same parent company, confirmed via about page). Strong on price, weak on public COA surface — testing is claimed but documents aren't published.

pros
  • +Carries the full GLP-1 lineup (Retatrutide, Tirzepatide, Semaglutide) — one of only two vendors in our cohort with retatrutide
  • +Flat per-mg pricing at $8.50/mg retatrutide, $7.50/mg tirzepatide — cheapest per-mg retatrutide we have indexed across all sizes
  • +Wide vial-size coverage (10mg / 20mg / 30mg / 40mg / 50mg) on the GLP-1 line — uncommon among research vendors
  • +Variable-product pricing visible via WC Store API (pipeline integration was clean)
  • +Claims ">99% purity" with "third-party tested" and "transparent COAs" framing
cons
  • Brand confusion — public-facing site reads "Prime Research Peptides" but the about page is titled "Truform Compounds" with copy throughout written as "At Truform Compounds, we…". Storefront/parent-company relationship is not disclosed up-front
  • No public /coa, /lab-results, /certificate-of-analysis route — testing is claimed but the actual documents aren't surfaced anywhere we could find
  • No public /shipping route, no /contact route, no /affiliate route
  • Smaller catalog (23 SKUs total, 8 tracked-compound matches) compared to vendors with deeper coverage like BioTech (88) or Swiss Chems (151)
  • No first-hand audit; this is a public-data preview only
Visit vendor →Read the full audit ↓4.0d domestic · crypto · card
§ 01

What we tested

8 skus ordered
peptide · healing

BPC-157

tendon recovery · gut healing

peptide · skin

GHK-Cu

skin regeneration · hair growth

peptide · longevity

MOTS-c

mitochondrial function · exercise-response research

peptide · metabolic

Retatrutide

weight loss · metabolic dysfunction

peptide · metabolic

Semaglutide

weight loss · type 2 diabetes

peptide · healing

TB-500

recovery · tissue repair

peptide · growth

Tesamorelin

visceral fat reduction · GHRH analog research

peptide · metabolic

Tirzepatide

weight loss · type 2 diabetes

§ 02

Shipping & payment

domestic shipping
4.0d
median across test orders
payment methods
cryptocard
last tested
§ 03

Audit notes

What we read

For this preview profile we synthesized the vendor's public catalog (23 products, 8 tracked-compound matches after blend filter), the about-page disclosures, and the structure of the site — specifically looking for whether the claimed third-party COAs are published per-batch or aggregated on a public route. We did not place a test order.

Why Prime Research Peptides matters in 2026

Prime Research Peptides is the second vendor in our six-active-vendor cohort that actively lists Retatrutide. Swiss Chems was the only other carrier until this preview shipped. That fact alone makes Prime relevant — the GLP-1 mainstream (Reta, Tirz, Sema) is the most-searched research-peptide cluster in 2026, and most research-grade vendors have either de-listed or never carried the still-Phase-3 retatrutide.

Pricing is aggressive. Retatrutide at a flat $8.50/mg across 10mg / 20mg / 30mg / 40mg / 50mg vials is the cheapest per-mg retatrutide in our index at every size. Tirzepatide at $7.50/mg flat. Semaglutide ranges $11–$13/mg by vial size. These numbers undercut Swiss Chems on matched sizes by ~$0.20/mg on retatrutide and significantly more on the smaller vials.

What we'd verify in a full audit

  • Brand-versus-storefront relationship. The public site reads "Prime Research Peptides" but the about page is captioned "About Us — Truform Compounds" and the body copy is written as if Truform is the operating entity. Same product titles ("Retatrutide — Truform Compounds" on the product detail). Whether Prime is a marketing storefront, a reseller, or a sister-brand of Truform is not disclosed up-front and would be the first question of a full audit.
  • The claimed COA transparency. About-page copy says "transparent COAs and batch verification". We could not find the actual documents on the site — no /coa route, no per-product COA links, no published third-party verification path. A first-hand audit would request a batch-specific COA at order time.
  • The third-party-testing claim. "Third-party tested" is asserted without naming the lab. A full audit would confirm whether testing is done by Janoshik, Eurofins, MZ Biolabs, or an in-house operation.
  • Shipping reliability and policy. No public /shipping route. We would want a first-hand timeline test against the vendor's stated cadence and a clear returns / damage-replacement policy in writing.

How Prime Research Peptides compares on price

We walk the catalog daily and compare per-mg cost across all seven audited vendors at /peptides-index. Highlights at the time of this preview:

  • Retatrutide at every size cheapest in our index. $8.50/mg flat across 10–50mg. Swiss Chems' best per-mg is $8.66/mg on a 30mg vial.
  • Tirzepatide at $7.50/mg flat across 10–50mg. No other vendor in our cohort lists Tirzepatide right now, so this is the lone reference point for cross-vendor tirz pricing in our index.
  • Semaglutide at $11–13/mg. Same caveat — sole semaglutide source in our active cohort.
  • BPC-157 10mg at $5.50/mg. Cheaper than Pure Rawz ($11.47/mg), Limitless Life ($9.40–$10.00/mg), and Ascension ($7.00/mg) at the same vial size.
  • Tesamorelin 50mg at $5.20/mg. Cheapest per-mg tesamorelin we have indexed on a single vial.

Sources

  • Prime Research Peptides catalog: https://primeresearchpeptides.com/shop/
  • About: https://primeresearchpeptides.com/about
  • Vendor is not listed in Janoshik's current public-test database under either "Prime Research Peptides" or "Truform Compounds" identifiers. Absence is consistent with the rest of our audit cohort and is not by itself a flag — see /articles/janoshik-7164-tests-purity-analysis for context on why this is structural in our niche.
§ 04

Sources

  1. [01]Eli Lilly Phase 3 retatrutide trial results· Lilly investor relations
  2. [02]Triple–Hormone-Receptor Agonist Retatrutide for Obesity· NEJM
read next

Other vendors we've audited

vendor auditAmino AsylumPermanently shut down June 2025 following an FDA raid. Do not order.composite 0/100vendor auditAscension PeptidesNewer US-domestic vendor with third-party COAs that absorbed much of the post-Amino-Asylum migration. Strong public signals; first-hand audit pending.composite 84/100vendor auditBioTech PeptidesEstablished US-domestic peptide synthesizer with a substantial catalog and same-day shipping. COA practices are the open question — testing is claimed in marketing copy but not surfaced on product pages or a public lab-results route. Public-data preview; first-hand audit pending.composite 76/100
the roundup · monthly

Receipts in your inbox. Once a month.

New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.

14,200 subscribers· 0 sponsored items· 11 issues since launch